Skip to main content

Table 2 Comparison between the studied groups regarding LHRmRNA tissue expression

From: Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways

RQ of LHRmRNA Group H P
Control Benign Borderline Malignant
• Mean 0.065 1.426 19.998 25.047 0.001*
• SD 0.073 0.900 31.066 53.626
  1. RQ relative quantification, H Kruskal-Wallis test, *P < 0.05 (significant)